Trials / Conditions / Prostatic Diseases

Prostatic Diseases

23 registered clinical trials studyying Prostatic Diseases — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617 NCT06785636	Pathos AI, Inc.	Phase 1 / Phase 2
Recruiting	18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prost NCT06706921	VA Greater Los Angeles Healthcare System	Phase 4
Recruiting	European Registry for Transperineal Laser Ablation of Prostate (TPLA) for Lower Urinary Tract Symptoms NCT06564415	University of Florence	—
Completed	Standardization of Prostatic Resection by Virtual Computational Reconstruction and Computational Flow Dynamics NCT05941260	Ain Shams University	—
Recruiting	Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for Canc NCT05574647	Imperial College London	N/A
Recruiting	Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection NCT05413850	Blue Earth Therapeutics Ltd	Phase 1 / Phase 2
Completed	Hypnosis Mask: a New Approach to Management of Pain in Medical Imaging NCT03711643	University Hospital, Lille	N/A
Completed	Low-energy Extracorporeal Shockwave Treatment for Patients After Radical Prostatectomy NCT03192917	University of Southern Denmark	N/A
Completed	Health Gatherings - For Your Health After Cancer NCT03344757	University of Miami	N/A
Completed	Prostatic Artery Embolization for Obstructive Uropathy Due to Prostate Cancer NCT03104907	Rigshospitalet, Denmark	N/A
Completed	Prostatic Artery Embolization for Benign Prostatic Obstruction NCT03099421	Rigshospitalet, Denmark	N/A
Terminated	Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer NCT02606123	ESSA Pharmaceuticals	Phase 1 / Phase 2
Unknown	A Prospective Trial of Povidone-iodine Suppository Before Transrectal Ultrasound Guided Prostate Biopsy NCT02245334	Seoul National University Hospital	Phase 4
Completed	Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasi NCT02074644	João Martins Pisco	N/A
Terminated	Character Traits and Stress in Suspected Prostate Cancer NCT02031029	Helse Stavanger HF	—
Active Not Recruiting	MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness NCT01464216	Oslo University Hospital	—
Completed	Test Semiquantitative Prostate Specific Antigen (PSA) NCT00853710	Institut Curie	N/A
Terminated	A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer NCT00672009	Cedars-Sinai Medical Center	Phase 2
Completed	Benign Prostatic Hyperplasia in Taiwan NCT00941343	Sanofi	N/A
Completed	Transluminal Flexible Endoscopic Procedure in Foregut and Urologic Surgery NCT00484783	University Hospitals Cleveland Medical Center	N/A
Completed	Alfuzosin XL Lower Urinary Tract Symptoms Efficacy and Sexuality Study NCT00575913	Sanofi	Phase 4
Completed	Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy NCT01316458	Novartis Pharmaceuticals	Phase 2
Approved For Marketing	Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate Cancer NCT04452136	Jeanne Link	—